Featuring perspectives from Dr Luis Paz-Ares and Dr Misty Dawn Shields, including the following topics:
- Introduction: Tail on the Curve? (0:00)
- First-Line Chemoimmunotherapy (10:45)
- Maintenance Lurbinectedin (28:42)
- Second-Line Treatment, Tarlatamab (45:35)
- Ongoing Research (53:20)
